Area of research
Endocrinology, Diabetes and Metabolism · Reproductive Medicine
Research interest
Research interests include Medicine, Internal medicine, Endocrinology, Apolipoprotein B, and Lipoprotein.
Reductions in serum levels of <scp>LDL</scp> cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver‐selective thyroid hormone receptor agonist eprotirome
Policy Decisions on Endocrine Disruptors Should Be Based on Science Across Disciplines: A Response to Dietrich et al.
Policy Decisions on Endocrine Disruptors Should Be Based on Science across Disciplines: A Response to Dietrich et al.
Reprint of: Policy decisions on endocrine disruptors should be based on science across disciplines: A response to Dietrich et al.
Policy decisions on endocrine disruptors should be based on science across disciplines
Reprint of: Policy decisions on endocrine disruptors should be based on science across disciplines: A response to Dietrich, et al.
Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich<i>et al</i>.